[go: up one dir, main page]

AR061485A1 - Composiciones estabilizadas de tetraciclina - Google Patents

Composiciones estabilizadas de tetraciclina

Info

Publication number
AR061485A1
AR061485A1 ARP070102646A ARP070102646A AR061485A1 AR 061485 A1 AR061485 A1 AR 061485A1 AR P070102646 A ARP070102646 A AR P070102646A AR P070102646 A ARP070102646 A AR P070102646A AR 061485 A1 AR061485 A1 AR 061485A1
Authority
AR
Argentina
Prior art keywords
tetracicline
stabilized
compositions
suspension
solution
Prior art date
Application number
ARP070102646A
Other languages
English (en)
Original Assignee
Serenex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serenex Inc filed Critical Serenex Inc
Publication of AR061485A1 publication Critical patent/AR061485A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un envase que comprende una primera forma de dosificacion que se desintegra rápidamente que comprende tetraciclina y una segunda forma de dosificacion que se desintegra rápidamente que comprende un buffer. Métodos para tratar o prevenir la mucositis, que comprenden mezclar las formas de dosificacion del envase en un medio acuoso para formar una solucion o suspension y administrar la solucion o suspension topicamente a la cavidad oral de un paciente. Una formulacion acuosa que comprende la primera y segunda formas de dosificacion en un medio acuoso.
ARP070102646A 2006-06-15 2007-06-15 Composiciones estabilizadas de tetraciclina AR061485A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81392506P 2006-06-15 2006-06-15
US81425506P 2006-06-16 2006-06-16

Publications (1)

Publication Number Publication Date
AR061485A1 true AR061485A1 (es) 2008-08-27

Family

ID=38610683

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102646A AR061485A1 (es) 2006-06-15 2007-06-15 Composiciones estabilizadas de tetraciclina

Country Status (4)

Country Link
US (1) US20080039433A1 (es)
AR (1) AR061485A1 (es)
TW (1) TW200815020A (es)
WO (1) WO2007147133A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007146981A2 (en) 2006-06-15 2007-12-21 Boehringer Ingelheim International Gmbh 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
EP3817738A4 (en) * 2018-07-02 2022-04-06 CelaCare Technologies, Inc. Compositions and methods for treatment of oral ulceration and oral mucositis

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions
DE2001604C2 (de) * 1970-01-15 1983-04-14 Pfizer Gmbh, 7500 Karlsruhe Verwendung von Polyäthylenglykol zur Herstellung von Oxytetracyclinlösungen zur parenteralen, peroralen und lokalen Anwendung
US3966808A (en) * 1974-06-19 1976-06-29 Rachelle Laboratories Italia, S.P.A. Manufacture of 6-methylenetetracyclines
EP0084705B1 (en) * 1981-12-11 1987-01-14 JOHN WYETH & BROTHER LIMITED Process for preparing solid shaped articles
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
US5558880A (en) * 1989-12-22 1996-09-24 Janssen Pharmaceutica Inc. Pharmaceutical and other dosage forms
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
US5046618A (en) * 1990-11-19 1991-09-10 R. P. Scherer Corporation Child-resistant blister pack
US5420272A (en) * 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5284963A (en) * 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
SG47520A1 (en) * 1992-08-13 1998-04-17 American Cyanamid Co New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
CA2144538C (en) * 1992-09-30 2003-12-23 Andrew Roy Thompson Stepped-edge blister pack and use of steps
US5343672A (en) * 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
ES2162867T3 (es) * 1993-07-09 2002-01-16 Scherer Corp R P Metodo de fabricacion de formas de dosificacion de farmacos liofilizados.
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
US5837287A (en) * 1994-10-28 1998-11-17 R P Scherer Corporation Process for preparing solid pharmaceutical dosage forms
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9702799D0 (en) * 1997-02-12 1997-04-02 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
PT1212050E (pt) * 1999-09-14 2007-03-30 Mucosal Therapeutics Llc Formulações contendo tetraciclinas para tratar ou evitar a mucosite
SI21221A (sl) * 2002-06-21 2003-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Hitro razpadljive tablete

Also Published As

Publication number Publication date
US20080039433A1 (en) 2008-02-14
TW200815020A (en) 2008-04-01
WO2007147133A1 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
CL2008000893A1 (es) Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal.
CL2008000895A1 (es) Composición para el cuidado oral que comprende un aminoácido fundamental; una fracción de partículas pequeñas y un agente antimicrobiano y su uso para reducir o prevenir las caries dentales, lesiones del esmalte, desmineralización, hipersensibilidad dental, gingivitis, entre otras.
CO6341541A2 (es) Composiciones para el cuidado oral que comprenden capsulas
CL2008000897A1 (es) Sal de arginina y uno o mas ácidos conjugados; composición de cuidado oral que comprende dicha sal; uso para reducir o inhibir la formacion de caries, desmineralizacion de los dientes; reducir la hipersensibilidad de los dientes, reducir o inhibir la gingivitos entre otras.
BRPI0921002A8 (pt) Composições para tratamento bucal compreendendo sílica fundida e seu uso
CO6480985A2 (es) Formulaciones para el tratamiento del dolor tisular profundo
AR063892A1 (es) Particulas de suministro que contienen agentes beneficos
ES2556585T3 (es) Composiciones que comprenden sulfato de salbutamol
AR033418A1 (es) Preparado farmaceutico mucoadhesivo desintegrable para la administracion de sustancia activa en medicina veterinaria y humana
AR075355A1 (es) Particula de suministro que contiene agentes beneficos
AR059456A1 (es) Agente benefico que comprende particulas de suministro
AR059174A1 (es) Formas farmaceuticas en forma de pelicula para usar en la cavidad bucal (obleas)
CO6290631A2 (es) Composición oral que contiene amino ácidos y un agente blanqueador
MXPA05007643A (es) Metodo para producir una forma farmaceutica oral con desintegracion inmediata y liberacion de ingrediente activo.
AR054227A1 (es) Composicion de principios activos
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
NO20075111L (no) Farmasoytisk sammensetning
ECSP10010514A (es) Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente
AR052854A1 (es) Metodo para reducir la inflamacion del tejido oral utilizando extracto de magnolia
UY33984A (es) Uso de 2,3-dihidroimidazo [1,2-c] quinazolinas sustituidas
AR109263A2 (es) Composición que comprende moxidectina
AR077138A1 (es) Composiciones farmaceuticas utiles para tratar el vhc
AR077125A1 (es) Combinaciones farmaceuticas utiles para tratar el vhc
AR089509A1 (es) Metodo para tratar la perdida osea alveolar, un implante dental, un anticuerpo antiesclerostina, un gel o matriz que comprende dicho anticuerpo y uso
UY31788A (es) Formulación farmacéutica sólida con liberación retardada

Legal Events

Date Code Title Description
FB Suspension of granting procedure